Mitigation of radiation exposure during surgical hepatectomy after yttrium-90 radioembolization

被引:3
作者
Decoteau, Mary A. [1 ,2 ,3 ]
Steuterman, Steven [1 ,2 ,4 ]
Kurian, Sunil M. [1 ,2 ,5 ]
Case, Jamie [1 ,2 ,5 ]
Lewis, Paul R. [1 ,2 ,3 ]
Fisher, Jonathan S. [1 ,2 ]
Schaffer, Randolph L. [1 ,2 ]
Marsh, Christopher L. [1 ,2 ,5 ]
机构
[1] Scripps Clin, Scripps Ctr Organ & Cell Transplantat, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA
[2] Scripps Green Hosp, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA
[3] Naval Med Ctr San Diego, Dept Gen Surg, San Diego, CA USA
[4] Scripps Clin, Dept Med Phys & Radiat Safety, La Jolla, CA USA
[5] Scripps Green Hosp, Scripps Clin Biorepository & Bioinformat Core, La Jolla, CA USA
关键词
radiation; exposures; Y-90; liver; safety; surgeons; SECONDARY LIVER MALIGNANCIES; ART BRACHYTHERAPY TREATMENT; MICROSPHERE BRACHYTHERAPY; HEPATOCELLULAR-CARCINOMA; RECOMMENDATIONS;
D O I
10.1088/1361-6498/ac09c0
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Yttrium-90 (Y-90) radioembolization for the treatment of hepatocellular carcinoma can present safety challenges when transplanting recently treated Y-90 patients. To reduce surgeons' contact with radioactive tissue and remain within occupational dose limits, current guidelines recommend delaying transplants at least 14 days, if possible. We wanted to determine the level of radiation exposure to the transplant surgeon when explanting an irradiated liver before the recommended decay period. An ex-vivo radiation exposure analysis was conducted on the explanted liver of a patient who received Y-90 therapy 46 h prior to orthotopic liver transplant. To estimate exposure to the surgeon's hands, radiation dosimeter rings were placed inside three different surgical glove configurations and exposed to the explanted liver. Estimated radiation doses corrected for Y-90 decay were calculated. Radiation safety gloves performed best, with an average radiation exposure rate of 5.36 mSV h(-1) in the static hand position, an 83% reduction in exposure over controls with no glove (31.31 mSv h(-1)). Interestingly, non-radiation safety gloves also demonstrated reduced exposure rates, well below occupational regulation limits. Handling of Y-90 radiated organs within the immediate post-treatment period can be done safely and does not exceed federal occupational dose limits if appropriate gloves and necessary precautions are exercised.
引用
收藏
页码:N1 / N11
页数:11
相关论文
共 14 条
  • [1] Berkeley Lab, 2018, Y 90 HANDL PREC PDF
  • [2] Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere brachytherapy in the treatment of hepatic malignancies
    Dezarn, William A.
    Cessna, Jeffery T.
    DeWerd, Larry A.
    Feng, Wenzheng
    Gates, Vanessa L.
    Halama, James
    Kennedy, Andrew S.
    Nag, Subir
    Sarfaraz, Mehrdad
    Sehgal, Varun
    Selwyn, Reed
    Stabin, Michael G.
    Thomadsen, Bruce R.
    Williams, Lawrence E.
    Salem, Riad
    [J]. MEDICAL PHYSICS, 2011, 38 (08) : 4824 - 4845
  • [3] Radiation exposure during liver surgery after treatment with 90Y microspheres, evaluated with computer simulations and dosimeter measurements
    Hogberg, Jonas
    Rizell, Magnus
    Hultborn, Ragnar
    Svensson, Johanna
    Henrikson, Olof
    Gjertsson, Peter
    Bernhardt, Peter
    [J]. JOURNAL OF RADIOLOGICAL PROTECTION, 2012, 32 (04) : 439 - 446
  • [4] Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the Radioembolization Brachytherapy Oncology Consortium
    Kennedy, Andrew
    Nag, Subir
    Salem, Riad
    Murthy, Ravi
    McEwan, Alexander J.
    Nutting, Charles
    Benson, Al, III
    Espat, Joseph
    Bilbao, Jose Ignacio
    Sharma, Ricky A.
    Thomas, James P.
    Coldwell, Douglas
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01): : 13 - 23
  • [5] Yttrium-90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma:: Downstaging to resection, RFA and bridge to transplantation
    Kulik, Laura M.
    Atassi, Bassel
    Van Holsbeeck, Lodewijk
    Souman, Tameem
    Lewandowski, Robert J.
    Mulcahy, Mary F.
    Hunter, Russell D.
    Nemcek, Albert A., Jr.
    Abecassis, Michael M.
    Haines, Kenneth G., III
    Salem, Riad
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2006, 94 (07) : 572 - 586
  • [6] Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma
    Labgaa, Ismail
    Tabrizian, Parissa
    Titano, Joseph
    Kim, Edward
    Thung, Swan N.
    Florman, Sander
    Schwartz, Myron
    Melloul, Emmanuel
    [J]. HPB, 2019, 21 (11) : 1497 - 1504
  • [7] Memon AG, 2016, INT J HEALTH SCI-IJH, V10, P279
  • [8] Radioembolization with yttrium-90 microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies - Part 3: Comprehensive literature review and future direction
    Salem, Riad
    Thurston, Kenneth G.
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (10) : 1571 - 1593
  • [9] Yttrium-90 microspheres for the treatment of hepatocellular carcinoma: A review
    Salem, Riad
    Hunter, Russell D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (02): : S83 - S88
  • [10] Radioembolization with 90Yttrium microspheres:: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies -: Part 2:: Special topics
    Salem, Riad
    Thurston, Kenneth G.
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 17 (09) : 1425 - 1439